Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Paul M. Parker Educates Paramus Patients on the Realities of Stem Cell Facelifts
  • USA - English


News provided by

Parker Center for Plastic Surgery

Aug 13, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Patients need to review procedures carefully before investing in the latest, trendiest cosmetic procedure.

Post this

Paramus, NJ (PRWEB) August 13, 2013 -- To keep his patients informed, Dr. Paul M. Parker of the Parker Center for Plastic Surgery has posted a blog detailing a new procedure known as a “stem cell facelift” and how it compares to current approved treatments. “Stem cell facelift” is actually a marketing term for fat transfer injections. While doctors who offer these procedures say that they use a centrifuge (or other proprietary method) to separate stem cells from ordinary fat cells, leading researchers in the field state that there is no scientific evidence that these “stem cells” perform better as a facial filler.

A combined task force of the American Society for Plastic Surgeons (ASPS) and the American Society for Aesthetic Plastic Surgery (ASAPS) was formed in order to evaluate some of the claims being made about stem cell facelifts. Dr. Parker said, "They reviewed thousands of articles published in peer-reviewed journals regarding the use of stem cells in cosmetic procedures and did not find clinical data to support the claims being made."

Fat injections are something that plastic surgeons have been using for years to increase facial fullness. Most plastic surgeons like Dr. Parker use facial fat injections as a stand-alone procedure or in conjunction with a traditional surgical facelift.

A traditional facelift is a surgical procedure that uses incisions to remove excess facial skin and tighten the skin remaining on the face. Additionally, the Parker Center bi-planer SMAS facelift includes lifting and tightening the underlying soft tissues to provide better facial structure. Judicious fat injections may also be used to replace the facial fat which atrophies with aging and create a youthful, fuller face. By using these additional procedures, Dr. Parker is able to remove less skin and create a more natural-looking result.

Since traditional fat injections will naturally contain some stem cells, the task force has recommended that providers not use the term “stem cell” but rather use the more accurate term “fat grafting." It's also recommended that surgeons stop using the term "stem cell facelift" for marketing purposes, as it is currently unsupported by scientific data. Those providers who do use stem cell therapy in fat grafting should do so only under Institutional Review Board approval and in compliance with the FDA regulatory guidelines.

Dr. Parker has stated that he believes that plastic surgeons should adhere to the recommendations of the ASPS and ASAPS, who work to ensure patient safety until sufficient scientific evidence is available.

"Marketing, unfortunately, has leaped ahead of science in this case, and patients need to review procedures carefully before investing in the latest, trendiest cosmetic procedure," he said.

The bi-planer SMAS facelift with fat injections that Dr. Parker performs is estimated to last an average of eight to 12 years. This number varies based on several factors, such as a patient’s overall health, smoking history, skin quality, future skin care maintenance, and weight fluctuations. Facelifts are surgeries that are described as “resetting the clock” in relation to the signs of aging. Dr. Parker typically reviews photos of his facelift patients when they were younger to facilitate their surgical goals.

Surgeries at the Parker Center for Plastic Surgery are performed at Surgiplex, the onsite, state of the art, fully certified ambulatory surgical center. This 2,100-square-foot facility was designed and built with patient safety in mind. Facelift patients are monitored overnight in the facility with a registered nurse one on one.

Dr. Paul M. Parker can be contacted at Parker Center for Plastic Surgery 122 E. Ridgewood Avenue, Paramus, NJ 07652 or at (201) 967-1212. Visit http://www.parkercenter.net for more information.

About Dr. Parker
Dr. Paul M. Parker is the medical director of both the Parker Center for Plastic Surgery and Beaura Spa. Dr. Parker has more than 20 years of experience as a plastic surgeon and has won numerous awards, including a recent “Patient’s Choice” award. He is board certified by the American Board of Plastic Surgery. He is also a fellow in the American Academy of Surgeons and a member of the American Society of Plastic Surgeons, American Society of Aesthetic Plastic Surgeons and the New Jersey Society of Plastic Surgeons, among others.

Janet Franceschi, Parker Center for Plastic Surgery, http://www.parkercenter.net/, 201-967-1212, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.